University of Texas Southwestern Medical Center-医療機器分野:企業M&A・提携分析

◆英語タイトル:University of Texas Southwestern Medical Center - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011247
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master’s degree in business administration, public health, medical scientist training program and bachelor of arts in biology. It offers training programs in various fields. The center carries out research activities in the areas of oncology, diabetes, obesity, cardiology, metabolism and nutrition, trauma and others. It operates through its academic medical centers, patient care providers and research institutions. UTSMC is headquartered in Dallas, Texas, the US.

University of Texas Southwestern Medical Center – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Texas Southwestern Medical Center, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
University of Texas Southwestern Medical Center, Medical Equipment Deals By Type, 2011 to YTD 2017 6
University of Texas Southwestern Medical Center, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
University of Texas Southwestern Medical Center, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
University of Texas Southwestern Medical Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
University of Texas Southwestern Medical Center, Medical Equipment, Deal Details 10
Partnerships 10
Peregrine Pharma Enters into Licensing Agreement with University of Texas Southwestern Medical Center 10
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 11
Biocept Enters into Agreement with University of Texas Southwestern Medical Center 13
Exalenz Bioscience Enters into Agreement with ALFSG 14
University of Texas Southwestern Medical Center – Key Competitors 15
University of Texas Southwestern Medical Center – Key Employees 16
University of Texas Southwestern Medical Center – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Product News 19
Aug 08, 2017: University of Texas Southwestern: Magnetic fields turn up the heat on bacterial biofilms 19
May 01, 2017: Stereotactic radiation highly effective for kidney cancer 21
Dec 06, 2016: Researchers find new biomarker for brain cancer prognosis 22
Oct 24, 2016: Study links small RNA molecule to pregnancy complication 23
Oct 13, 2016: Imaging with new biomarker tracks tumor progression, response to brain cancer treatment 25
Sep 14, 2016: Fusion targeted prostate biopsy proves more accurate in diagnosis of prostate cancer 27
Aug 22, 2016: Novel MRI technique distinguishes healthy prostate tissue from cancer using zinc 29
Aug 15, 2016: Expanded role of PARP proteins opens the door to explore new therapeutic targets in cancer, other diseases 30
Apr 19, 2016: Plastic surgeons develop innovative microsurgery technique for reconstructing breast after mastectomy 31
Apr 18, 2016: Research shows 98% cure rate for prostate cancer using Stereotactic Body Radiation Therapy 32
Feb 26, 2016: Light reflectance technique improves ability to remove prostate cancer during surgery 34
Other Significant Developments 35
Nov 01, 2017: OpenTempo expands its partnership with The University of Texas Southwestern 35
Jul 21, 2016: UTA and UT Southwestern partner to improve accuracy of cancer radiation therapy delivery 36
May 17, 2016: Cancer Prevention and Research Institute of Texas Marks Progress at the Halfway Point of its Funding 37
Mar 02, 2016: UTSW collaborates to develop device to combat memory loss from brain injury, epilepsy, Alzheimer’s disease 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
University of Texas Southwestern Medical Center, Medical Equipment, Key Facts 2
University of Texas Southwestern Medical Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
University of Texas Southwestern Medical Center, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
University of Texas Southwestern Medical Center, Medical Equipment Deals By Type, 2011 to YTD 2017 6
University of Texas Southwestern Medical Center, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
University of Texas Southwestern Medical Center, Deals By Market, 2011 to YTD 2017 8
University of Texas Southwestern Medical Center, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Peregrine Pharma Enters into Licensing Agreement with University of Texas Southwestern Medical Center 10
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 11
Biocept Enters into Agreement with University of Texas Southwestern Medical Center 13
Exalenz Bioscience Enters into Agreement with ALFSG 14
University of Texas Southwestern Medical Center, Key Competitors 15
University of Texas Southwestern Medical Center, Key Employees 16
University of Texas Southwestern Medical Center, Other Locations 18
University of Texas Southwestern Medical Center, Subsidiaries 18

★海外企業調査レポート[University of Texas Southwestern Medical Center-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KornFerry International (KFY):企業の財務・戦略的SWOT分析
    KornFerry International (KFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PathoQuest SAS-医療機器分野:企業M&A・提携分析
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that offers game changing metagenomics approach to improve the breadth of pathogen detection. The company offers automated bioinformatics software that provide comprehensive pathogens database to produce microbiome reports. Its testing a …
  • MGM Resorts International:企業のM&A・事業提携・投資動向
    MGM Resorts International - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MGM Resorts International Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Bloomberg L.P.:企業の戦略・SWOT・財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Quad/Graphics, Inc.:企業の戦略・SWOT・財務情報
    Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Caledonia Investments plc:企業の戦略・SWOT・財務情報
    Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report Summary Caledonia Investments plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Key Tronic Corp (KTCC):企業の財務・戦略的SWOT分析
    Summary Key Tronic Corp (Key Tronic) is an electronic manufacturing service provider that offers OEM manufacturing solutions. The company offers services such as product assembly, PCBA, PCBA rapid response center, molding, metal, tooling, program management, supply chain management, quality, testing …
  • Synedgen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synedgen Inc (Synedgen) is a biotechnology company that discovers and develops polysaccharide-based drugs, which enhance and mimic the innate immune system. The company’s pipeline products include SYGN305, SYGN399, SYGN303, SYGN313 and SYGN309. Synedgen develops products for the treatment of …
  • Herantis Pharma Plc (HRTIS):製薬・医療:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • Avista Corporation
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Carna Biosciences Inc (4572):企業の財務・戦略的SWOT分析
    Summary Carna Biosciences Inc (Carna) is a biotechnology company that discovers and develops drugs for the treatment of cancer and inflammatory diseases. The company offers products such as kinase proteins, biotinylated kinases, substrates, assay kits, protein substrates, inactive kinases, inactive- …
  • PRA Health Sciences Inc (PRAH):医療機器:M&Aディール及び事業提携情報
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometri …
  • EnBW Energie Baden-Wurttemberg AG (EBK):石油・ガス:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析
    IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Trustwave Holdings Inc:企業の戦略的SWOT分析
    Trustwave Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bata India Limited:企業の戦略・SWOT・財務情報
    Bata India Limited - Strategy, SWOT and Corporate Finance Report Summary Bata India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tokyo Tatemono Co., Ltd.:企業の戦略・SWOT・財務情報
    Tokyo Tatemono Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Tatemono Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ProMIS Neurosciences Inc (PMN):企業の製品パイプライン分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of neurodegenerative disorders. Its major products include tests functional assa …
  • ASM International NV (ASM):企業の財務・戦略的SWOT分析
    ASM International NV (ASM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Symic Biomedical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Symic Biomedical Inc (Symic Biomedical) is a biopharmaceutical company that develops library of compounds that target and protect the ECM (extracellular matrix) from illness or injury-related degradation. The company’s ECM specific compounds facilitate local application, which enhances its a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆